Two Seattle Researchers Announced as Part of American Lung Association Research Team for 2019-2020
The American Lung Association expands its research investment to $8.7 million, making headway on its commitment to double its investment in research
(December 2, 2019) - SEATTLE, Wash.
For more information please contact:
The American Lung Association shared its 2019-2020 research team, which includes Kristina Crothers of the University of Washington and Christoph Grundner of Seattle Children’s Hospital for their respective work in lung cancer research and mycobacterium tuberculosis treatment.
The Lung Association has also increased its research investment to $8.7 million, through awards for both our Airways Clinical Research Center (ACRC) Network and its innovative Awards & Grants program. This announcement comes at an important time, as November is Lung Cancer Awareness Month. With a vision of a world free of lung disease, the American Lung Association funds a wide range of research to improve lung health, including lung cancer, asthma, chronic obstructive pulmonary disease (COPD) pulmonary fibrosis and more.
“The Lung Association is extremely proud to support the lifesaving work of two more medical researchers working here in Washington,” said Allison Hickey, Executive Vice President of the American Lung Association in Washington. “We are doubling our commitment to support groundbreaking research in service of our mission to save lives by improving lung health and preventing lung disease in Washington and throughout the country.”
The Awards and Grants Program provides investigators with the funds, at all levels of their career, to conduct novel and promising research to prevent, treat and even cure lung disease. The ACRC is the nation's largest not-for-profit network of clinical research centers dedicated to asthma and COPD treatment research that promises to have a direct, positive impact on patient care.
Crothers’s research is focused on communicating results of lung cancer screening to patients. Grundner’s research focuses on developing new treatments for drug-resistant mycobacterium tuberculosis.
Lung cancer is the #1 cancer killer of both women and men in the U.S. During November’s Lung Cancer Awareness Month, the American Lung Association’s LUNG FORCE initiative is dedicated to increasing awareness about the risk of this deadly disease and uniting Americans to raise funds for critical lung cancer research.
Research projects funded by the Lung Association are carefully selected through rigorous scientific review and represent the investigation of a wide range of complex issues to help combat and reduce the suffering and burden of lung disease. See project overviews of all funded projects at Lung.org/research-team.
For media interested in speaking with an expert about lung health and the American Lung Association Research Team, contact Holly Harvey at [email protected] or 206-512-3292.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the coveted 4-star rating from Charity Navigator and a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.
Sign up for the latest lung health news sent right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.